Henry Schein/$HSIC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Henry Schein
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Ticker
$HSIC
Sector
Primary listing
Industry
Health Care Providers & Services
Headquarters
Employees
25,000
ISIN
US8064071025
Website
Henry Schein Metrics
BasicAdvanced
$8.9B
22.79
$3.21
0.87
-
Price and volume
Market cap
$8.9B
Beta
0.87
52-week high
$82.49
52-week low
$60.56
Average daily volume
1.6M
Financial strength
Current ratio
1.384
Quick ratio
0.585
Long term debt to equity
47.129
Total debt to equity
68.32
Interest coverage (TTM)
5.65%
Profitability
EBITDA (TTM)
1,036
Gross margin (TTM)
31.60%
Net profit margin (TTM)
3.21%
Operating margin (TTM)
6.01%
Effective tax rate (TTM)
24.08%
Revenue per employee (TTM)
$510,000
Management effectiveness
Return on assets (TTM)
4.61%
Return on equity (TTM)
8.47%
Valuation
Price to earnings (TTM)
22.792
Price to revenue (TTM)
0.725
Price to book
2.7
Price to tangible book (TTM)
-5.34
Price to free cash flow (TTM)
18.079
Free cash flow yield (TTM)
5.53%
Free cash flow per share (TTM)
404.61%
Growth
Revenue change (TTM)
1.75%
Earnings per share change (TTM)
8.11%
3-year revenue growth (CAGR)
0.04%
10-year revenue growth (CAGR)
1.99%
3-year earnings per share growth (CAGR)
-11.22%
10-year earnings per share growth (CAGR)
1.59%
What the Analysts think about Henry Schein
Analyst ratings (Buy, Hold, Sell) for Henry Schein stock.
Bulls say / Bears say
KKR's strategic investment of 12% in Henry Schein, with options to increase to nearly 15%, brings operational expertise and potential for enhanced shareholder value. (bloomberg.com)
Henry Schein's restructuring plan aims to achieve savings at the high end of its $75 million to $100 million goal by the end of 2025, potentially improving profitability. (reuters.com)
The company's focus on operational improvements, supported by KKR's investment and new board additions, sets the stage for potential growth and enhanced competitiveness. (reuters.com)
Henry Schein forecasts 2025 adjusted per-share profit below Wall Street estimates, citing weak demand for dental products amid persistent inflation. (reuters.com)
The company reported quarterly revenue of $3.19 billion, missing estimates of $3.29 billion, indicating potential challenges in meeting market expectations. (reuters.com)
Analysts have expressed concerns over Henry Schein's fundamental growth rate, with expected revenue growth in 2024 being inflated by non-core business factors, leading to a 'Sell' rating. (markets.businessinsider.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.
Henry Schein Financial Performance
Revenues and expenses
Henry Schein Earnings Performance
Company profitability
Henry Schein News
AllArticlesVideos
Updated: Henry Schein to Participate in Upcoming Investor Conference in June
Business Wire·4 weeks ago
Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10%
Business Wire·1 month ago
Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Henry Schein stock?
Henry Schein (HSIC) has a market cap of $8.9B as of June 27, 2025.
What is the P/E ratio for Henry Schein stock?
The price to earnings (P/E) ratio for Henry Schein (HSIC) stock is 22.79 as of June 27, 2025.
Does Henry Schein stock pay dividends?
No, Henry Schein (HSIC) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Henry Schein dividend payment date?
Henry Schein (HSIC) stock does not pay dividends to its shareholders.
What is the beta indicator for Henry Schein?
Henry Schein (HSIC) has a beta rating of 0.87. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.